Izuchukwu Favour Obilom

Izuchukwu Favour Obilom

Auto-generated profile, based on publicly available information

Izuchukwu Favour Obilom

Department of Clinical Pharmacy and Pharmacy Management, University of Nigeria, Nsukka, Nigeria

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Decoding Infection and Transmission
Verified
Journal Article
Open access
IOIkechukwu Emmanuel Onwunta
Ikechukwu Emmanuel Onwunta
GOGerald Ozota
Gerald Ozota
CEChizaram Adaeze Eze
Chizaram Adaeze Eze
IOIzuchukwu Favour Obilom
Izuchukwu Favour Obilom
OOOnyeka Chinenye Okoli
Onyeka Chinenye Okoli
EAEbube Lilian Agbo
Ebube Lilian Agbo

24 January 2025 in Pharmacy Education
Verified
Journal Article
Open access
PDF file
OOOlisaeloka Okoye
Olisaeloka Okoye
IOIzuchukwu Obilom
Izuchukwu Obilom
JOJubilee Orjiakor
Jubilee Orjiakor
IOIfeoma Okeke
Ifeoma Okeke
EUEvaristus Ugboma
Evaristus Ugboma
KAKosisochi Chinwendu Amorha
Kosisochi Chinwendu Amorha
Introduction: This study assessed the attitude and awareness of pharmacists in Southern Nigeria towards management and prevention of hepatitis B infection. Methods: A 39-item, structured questionnaire was distributed online via WhatsApp groups of the Pharmaceutical Society of Nigeria (PSN) technical groups in 17 Southern Nigerian states for 6 weeks (August to September 2024). Data from 255 responses were analysed using SPSS v22, with statistical significance set at P ≤0.05. Results: All respondents (100%) were aware of hepatitis B. Most (95.7%) knew that the virus could be transmitted via blood and blood products, and 73.7% knew that it could be transmitted from mother to child. In addition, 63.1 % identified Hepatitis B as a nosocomial infection and 96.1% knew about the availability of hepatitis B vaccine. Screening for hepatitis B was reported by 59.6%, whereas 48.6% had received formal training focused on hepatitis B. However, only 37.3% had been vaccinated, and 55.3% were unvaccinated. Conclusion: The study revealed that the respondents have good knowledge, awareness, and attitude towards the management and prevention of hepatitis B. However, this did not translate into optimal preventive practices. Specific training on hepatitis B should be incorporated into continuous professional development programs for pharmacists.